Jose Portilla-Arias
Nanomedicine Research Center,
Department of Neurosurgery,
Nanomedicine Research Center, Department of Neurosurgery
Cedars-Sinai Medical Center
Jose Portilla-Arias has not added Biography.
If you are Jose Portilla-Arias and would like to personalize this page please email our Author Liaison for assistance.
Nanostructurated complexes of poly(beta,L-malate) and cationic surfactants: synthesis, characterization and structural aspects.
Biomacromolecules Jan, 2006 | Pubmed ID: 16398511
Thermal decomposition of fungal poly(beta,L-malic acid) and Poly(beta,L-malate)s.
Biomacromolecules Nov, 2006 | Pubmed ID: 17096562
Ionic complexes of biosynthetic poly(malic acid) and poly(glutamic acid) as prospective drug-delivery systems.
Macromolecular bioscience Jul, 2007 | Pubmed ID: 17599336
Synthesis, degradability, and drug releasing properties of methyl esters of fungal poly(beta,L-malic acid).
Macromolecular bioscience Jun, 2008 | Pubmed ID: 18322913
Biodegradable nanoparticles of partially methylated fungal poly(beta-L-malic acid) as a novel protein delivery carrier.
Macromolecular bioscience Jun, 2008 | Pubmed ID: 18350538
Nanoparticles made of microbial poly(gamma-glutamate)s for encapsulation and delivery of drugs and proteins.
Journal of biomaterials science. Polymer edition , 2009 | Pubmed ID: 19454169
Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?
NeuroImage Jan, 2011 | Pubmed ID: 20149882
Temozolomide delivery to tumor cells by a multifunctional nano vehicle based on poly(β-L-malic acid).
Pharmaceutical research Nov, 2010 | Pubmed ID: 20387095
Inhibition of brain tumor growth by intravenous poly (β-L-malic acid) nanobioconjugate with pH-dependent drug release [corrected].
Proceedings of the National Academy of Sciences of the United States of America Oct, 2010 | Pubmed ID: 20921419
Polymalic acid-based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both HER2/neu receptor synthesis and activity.
Cancer research Feb, 2011 | Pubmed ID: 21303974
The optimization of polymalic acid peptide copolymers for endosomolytic drug delivery.
Biomaterials Aug, 2011 | Pubmed ID: 21514661
Poly(methyl malate) nanoparticles: formation, degradation, and encapsulation of anticancer drugs.
Macromolecular bioscience Oct, 2011 | Pubmed ID: 21793213
Nanobiopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancer.
PloS one , 2012 | Pubmed ID: 22355336
Nanoconjugate Platforms Development Based in Poly(β,L-Malic Acid) Methyl Esters for Tumor Drug Delivery.
Journal of nanotechnology , 2010 | Pubmed ID: 23024655
Distinct mechanisms of membrane permeation induced by two polymalic acid copolymers.
Biomaterials Jan, 2013 | Pubmed ID: 23063368
Cellular Delivery of Doxorubicin via pH-Controlled Hydrazone Linkage Using Multifunctional Nano Vehicle Based on Poly(β-L-Malic Acid).
International journal of molecular sciences , 2012 | Pubmed ID: 23109877
Polymalic acid nanobioconjugate for simultaneous immunostimulation and inhibition of tumor growth in HER2/neu-positive breast cancer.
Journal of controlled release : official journal of the Controlled Release Society Nov, 2013 | Pubmed ID: 23770212
Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment.
Journal of drug targeting Dec, 2013 | Pubmed ID: 24032759
Nanoparticles of Esterified Polymalic Acid for Controlled Anticancer Drug Release.
Macromolecular bioscience Jun, 2014 | Pubmed ID: 24902676
JoVEについて
Copyright © 2023 MyJoVE Corporation. All rights reserved